Avantax Planning Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $364K | Buy |
3,515
+536
| +18% | +$47.8K | 0.01% | 336 |
|
|
2026
Q1 | $214K | Buy |
2,979
+294
| +11% | +$22.6K | 0.01% | 403 |
|
|
2025
Q4 | $213K | Buy |
2,685
+29
| +1% | +$2.29K | 0.01% | 412 |
|
|
2025
Q3 | $200K | Buy |
+2,656
| New | +$182K | 0.01% | 428 |
|
|
2024
Q3 | – | Sell |
-4,366
| Closed | -$258K | – | 449 |
|
|
2024
Q2 | $258K | Sell |
4,366
-485
| -10% | -$30.3K | 0.01% | 388 |
|
|
2024
Q1 | $387K | Sell |
4,851
-1,483
| -23% | -$113K | 0.01% | 323 |
|
|
2023
Q4 | $500K | Sell |
6,334
-1,858
| -23% | -$132K | 0.02% | 238 |
|
|
2023
Q3 | $572K | Sell |
8,192
-6,484
| -44% | -$459K | 0.02% | 214 |
|
|
2023
Q2 | $1.01M | Buy |
14,676
+2,002
| +16% | +$142K | 0.04% | 162 |
|
|
2023
Q1 | $942K | Sell |
12,674
-349
| -3% | -$29.3K | 0.04% | 171 |
|
|
2022
Q4 | $1.21M | Sell |
13,023
-144
| -1% | -$13.9K | 0.05% | 142 |
|
|
2022
Q3 | $1.26M | Sell |
13,167
-337
| -2% | -$33.4K | 0.06% | 128 |
|
|
2022
Q2 | $1.25M | Sell |
13,504
-162
| -1% | -$15.8K | 0.05% | 131 |
|
|
2022
Q1 | $1.38M | Sell |
13,666
-331
| -2% | -$34.8K | 0.05% | 128 |
|
|
2021
Q4 | $1.44M | Sell |
13,997
-464
| -3% | -$42.9K | 0.06% | 126 |
|
|
2021
Q3 | $1.23M | Sell |
14,461
-14,093
| -49% | -$1.18M | 0.06% | 121 |
|
|
2021
Q2 | $2.38M | Buy |
28,554
+7,987
| +39% | +$654K | 0.11% | 78 |
|
|
2021
Q1 | $1.55M | Sell |
20,567
-3,631
| -15% | -$264K | 0.08% | 105 |
|
|
2020
Q4 | $1.65M | Sell |
24,198
-3,552
| -13% | -$231K | 0.09% | 94 |
|
|
2020
Q3 | $1.62M | Buy |
27,750
+482
| +2% | +$30K | 0.09% | 97 |
|
|
2020
Q2 | $1.77M | Buy |
27,268
+2,000
| +8% | +$126K | 0.1% | 88 |
|
|
2020
Q1 | $1.5M | Buy |
25,268
+15,341
| +155% | +$1.02M | 0.1% | 78 |
|
|
2019
Q4 | $738K | Sell |
9,927
-588
| -6% | -$41.3K | 0.04% | 135 |
|
|
2019
Q3 | $663K | Buy |
10,515
+164
| +2% | +$9.72K | 0.04% | 140 |
|
|
2019
Q2 | $573K | Sell |
10,351
-578
| -5% | -$31.1K | 0.04% | 155 |
|
|
2019
Q1 | $589K | Buy |
10,929
+2,259
| +26% | +$139K | 0.04% | 149 |
|
|
2018
Q4 | $568K | Sell |
8,670
-152
| -2% | -$11.3K | 0.04% | 135 |
|
|
2018
Q3 | $694K | Buy |
8,822
+291
| +3% | +$20.8K | 0.06% | 110 |
|
|
2018
Q2 | $549K | Buy |
8,531
+177
| +2% | +$11.7K | 0.05% | 127 |
|
|
2018
Q1 | $520K | Buy |
8,354
+494
| +6% | +$35.4K | 0.04% | 174 |
|
|
2017
Q4 | $570K | Sell |
7,860
-8,772
| -53% | -$638K | 0.05% | 154 |
|
|
2017
Q3 | $1.35M | Buy |
16,632
+645
| +4% | +$51K | 0.11% | 89 |
|
|
2017
Q2 | $1.29M | Buy |
15,987
+982
| +7% | +$77.5K | 0.11% | 89 |
|
|
2017
Q1 | $1.18M | Sell |
15,005
-4,254
| -22% | -$340K | 0.11% | 84 |
|
|
2016
Q4 | $1.52M | Buy |
+19,259
| New | +$1.56M | 0.16% | 62 |
|
Other funds holding CVS
CF
HCM
Avantax Planning Partners's CVS Position: Q2 2026 in Review
Avantax Planning Partners increased its CVS Health (CVS) stake by 18% in Q2 2026, buying an estimated $47.8K and bringing the position to 3,515 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #336.
Avantax Planning Partners first reported a position in CVS in Q4 2016 and has held it in 35 quarters since. The position peaked at $2.38M in Q2 2021. 886 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Avantax Planning Partners held 3,515 shares of CVS Health worth $364K as of Q2 2026.
- Avantax Planning Partners bought 536 CVS Health shares in Q2 2026, an estimated $47.8K.
- CVS Health made up 0.01% of Avantax Planning Partners's portfolio in Q2 2026, its #336 holding.
- Avantax Planning Partners first reported a position in CVS Health in Q4 2016 and has held it in 35 quarters since.
- Avantax Planning Partners's CVS Health position peaked at $2.38M in Q2 2021.
- 886 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Avantax Planning Partners's 13F filing for Q2 2026, filed 28 Jul 2026.